FDA cleared the Sofjec (Single use Needle); Sofjec (Single use Syringe with or without Needle); Sofjec (Membrane Filter Syringe) from Hlb Lifescience Co., Ltd. on May 21, 2026 under K253112, a special 510(k). The device falls under product code FMF, Syringe, Piston, regulated at 21 CFR 880.5860 as a Class 2 device. The review panel was General Hospital.
FDA logged the submission as received on Sep 24, 2025. The decision came 239 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
This is the only decision on file for Hlb Lifescience Co., Ltd. in the last 12 months of the tracker.
Questions & Answers
What did FDA clear under K253112?
K253112 is the FDA 510(k) for Sofjec (Single use Needle); Sofjec (Single use Syringe with or without Needle); Sofjec (Membrane Filter Syringe), submitted by Hlb Lifescience Co., Ltd.. FDA's decision date was May 21, 2026, under product code FMF (Syringe, Piston).
Who makes the Sofjec (Single use Needle); Sofjec (Single use Syringe with or without Needle); Sofjec (Membrane Filter Syringe)?
Hlb Lifescience Co., Ltd., based in Anseong-Si, is the applicant of record for K253112.
How long did the K253112 review take?
FDA received the submission on Sep 24, 2025 and issued its decision on May 21, 2026, 239 days later.